<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01478139</url>
  </required_header>
  <id_info>
    <org_study_id>LIFTplug-110212</org_study_id>
    <nct_id>NCT01478139</nct_id>
  </id_info>
  <brief_title>Ligation of Intersphincteric Fistula Tract (LIFT) Versus LIFT-plug Procedure for Anal Fistula Repair</brief_title>
  <acronym>LIFT-plug</acronym>
  <official_title>Ligation of Intersphincteric Fistula Tract (LIFT) Versus LIFT-plug Procedure for Anal Fistula Repair: a Multicenter, Randomized, Open-label, Parallel Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zhen Jun Wang</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Peking University Third Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tianjin Third Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Health Science Center of Xi'an Jiaotong University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shaanxi Provincial People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Beijing Chao Yang Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to validate the effect of Ligation of Intersphincteric Fistula&#xD;
      Tract (LIFT) Versus LIFT-plug procedure for Anal Fistula Repair.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The management of trans-sphincteric anal fistulae of cryptoglandular origin is challenging.&#xD;
      The ideal management is to effectively heal the fistula without compromising continence,&#xD;
      avoid fistula recurrence, and quick recovery. Ligation of the intersphincteric fistula tract&#xD;
      (LIFT) and LIFT reinforced with a bioprosthetic graft (BioLIFT) are two recently reported&#xD;
      procedures that showed improved healing results. In the LIFT, Rojanasakul et al proposed to&#xD;
      identify the fistula tract in the intersphincteric space and subsequent division and ligation&#xD;
      of the tract, and the primary healing rate was 94.4%. The following studies reported slightly&#xD;
      lower results, but the recurrence rate was as high as 18% to 28%. Ellis et al subsequently&#xD;
      described a modified LIFT procedure (BioLIFT procedure) in which a bioprosthetic was placed&#xD;
      in the intersphincteric plane to reinforce the closure of the fistula tract (BioLIFT&#xD;
      procedure), and yielded a healing rate of 94% in 31 patients who had a minimum of 1 year of&#xD;
      follow-up after their last treatment.&#xD;
&#xD;
      The investigators modified the LIFT procedure by combining LIFT with the technique of anal&#xD;
      fistula plug. The bioprosthetic plug was placed into the fistula tract through the opening in&#xD;
      the external sphincter to the external opening in the skin after LIFT procedure. The present&#xD;
      study was designed to assess the preliminary results of LIFT-Plug technique prospectively.&#xD;
&#xD;
      The purpose of this study is to validate the effect of Ligation of Intersphincteric Fistula&#xD;
      Tract (LIFT) Versus LIFT-plug procedure for Anal Fistula Repair.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2011</start_date>
  <completion_date type="Anticipated">November 2013</completion_date>
  <primary_completion_date type="Anticipated">November 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Healing time</measure>
    <time_frame>1month, 3 month, 6 month postoperatively</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>recurrence rate</measure>
    <time_frame>1month, 3 month, 6 month postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative pain</measure>
    <time_frame>1month, 3 month, 6 month postoperatively</time_frame>
    <description>The methodology used for the evaluation of postoperative perineal pain severity and relief, is the visual analogue scale (VAS) (1-10). We considered positive a VAS &gt; 4.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fecal incontinence</measure>
    <time_frame>1month, 3 month, 6 month postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>complication rates</measure>
    <time_frame>1month, 3 month, 6 month postoperatively</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Anorectal Fistula</condition>
  <condition>Extracellular Matrix Alteration</condition>
  <arm_group>
    <arm_group_label>LIFT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects randomized to this arm will receive the ligation of the intersphincteric fistula track (LIFT) procedure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LIFT-plug</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects randomized to this arm will receive the ligation of the intersphincteric fistula track and plug (LIFT-plug) procedure</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>LIFT-plug</intervention_name>
    <description>Subjects randomized to this arm will receive the ligation of the intersphincteric fistula track and plug (LIFT-plug) procedure</description>
    <arm_group_label>LIFT-plug</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>LIFT</intervention_name>
    <description>Subjects randomized to this arm will receive the ligation of the intersphincteric fistula track (LIFT) procedure</description>
    <arm_group_label>LIFT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female subjects over eighteen years old or less than 65 years old.&#xD;
&#xD;
          -  Able to understand and provide informed consent or have a legally authorized&#xD;
             representative capable of providing consent.&#xD;
&#xD;
          -  Clinical diagnosis of primary anal fistula categorized as trans-sphincteric fistula&#xD;
             tract determined to be of cryptoglandular origin (primary or recurrent).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Presence of horseshoe fistula.&#xD;
&#xD;
          -  History of immunosuppression therapy/treatment within previous six months.&#xD;
&#xD;
          -  Fistulas with active abscess, infection, or acute inflammation&#xD;
&#xD;
          -  History of Choron's Disease&#xD;
&#xD;
          -  History of Ulcerative Colitis&#xD;
&#xD;
          -  History of HIV or other immune system disease&#xD;
&#xD;
          -  History of collagen disease&#xD;
&#xD;
          -  History of radiation to the anorectal region&#xD;
&#xD;
          -  Allergies to pig tissue or pig products&#xD;
&#xD;
          -  Religious or cultural objection to the use of pig tissue&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zhen Jun Wang, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Beijing Chao Yang Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zhen Jun Wang, M.D.</last_name>
    <phone>86-1085231604</phone>
    <email>wang3zj@sohu.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Li Hua Tian, M.D.</last_name>
    <phone>86-1085231217</phone>
    <email>cyky003@yahoo.com.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Peking University Third Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chao Wen Chen, M.D.</last_name>
      <phone>86-013901038133</phone>
      <email>ccw0070890@sina.com</email>
    </contact>
    <investigator>
      <last_name>Chao Wen Chen, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beijing Chaoyang Hospital, Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100020</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhen Jun Wang, M.D.</last_name>
      <phone>86-013601393711</phone>
      <email>wang3zj@sohu.com</email>
    </contact>
    <investigator>
      <last_name>Zhen Jun Wang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shaanxi Provincial People's Hospital</name>
      <address>
        <city>Xi'an</city>
        <state>Shanxi</state>
        <zip>710000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiao Qiang Wang, M.D.</last_name>
      <phone>86-013991966126</phone>
      <email>Xiaoqiangwang2008@yahoo.cn</email>
    </contact>
    <investigator>
      <last_name>Xiao Qiang Wang, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Xi'an Jiaotong University College of Medicine</name>
      <address>
        <city>Xi'an</city>
        <state>Shanxi</state>
        <zip>710000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiang Ming Che, M.D.</last_name>
      <phone>86-018991232115</phone>
      <email>chexiang@mail.xjtu.edu.cn</email>
    </contact>
    <investigator>
      <last_name>Xiang Ming Che, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tianjin Third Central Hospital</name>
      <address>
        <city>Tianjin</city>
        <state>Tianjin</state>
        <zip>300000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wei Liang Song, M.D.</last_name>
      <phone>86-015522242541</phone>
      <email>songwl2008@sina.com</email>
    </contact>
    <investigator>
      <last_name>Wei Liang Song, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <study_first_submitted>November 10, 2011</study_first_submitted>
  <study_first_submitted_qc>November 22, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 23, 2011</study_first_posted>
  <last_update_submitted>November 26, 2013</last_update_submitted>
  <last_update_submitted_qc>November 26, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 28, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Chao Yang Hospital</investigator_affiliation>
    <investigator_full_name>Zhen Jun Wang</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>anorectal fistula</keyword>
  <keyword>acellular dermal matrix</keyword>
  <keyword>ligation of intersphincteric fistula tract</keyword>
  <keyword>ligation of intersphincteric fistula tract and plug</keyword>
  <keyword>complications of treatment</keyword>
  <keyword>recurrence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Fistula</mesh_term>
    <mesh_term>Fistula</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

